Conversely, following studies demonstrated an increase in resistin values in SSc patients with respect to controls [143,197,208,216,217], with higher resistin in patients with DUs [213], in patients developing new DUs after a 52-weeks follow-up [217], and in those with PAH [143]. The gene discussed is RETN; the disease is pulmonary arterial hypertension.